Literature DB >> 22911358

[Statement of the German Ophthalmology Society, the Retina Society and the Professional Association of German Ophthalmologists for the treatment of macular edema in retinal vein occlusion: therapeutic strategies].

.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22911358     DOI： 10.1007/s00347-012-2660-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  6 in total

1.  [Design of the ORCA module in the OCEAN study : Evaluation of SD-OCT results in daily routine practice].

Authors:  B Heimes; T Schick; C K Brinkmann; A Wiedon; B Haegele; B Kirchhof; F G Holz; D Pauleikhoff; F Ziemssen; S Liakopoulos; G Spital; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2016-07       Impact factor: 1.059

2.  Descemet membrane endothelial keratoplasty (DMEK) early stage graft failure in eyes with preexisting glaucoma.

Authors:  Maximilian Treder; Maged Alnawaiseh; Nicole Eter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-08       Impact factor: 3.117

3.  [Baseline diagnostics and initial treatment decision for anti-vascular endothelial growth factor treatment in retinal diseases : Comparison between results by study physician and reading centers (ORCA/OCEAN study)].

Authors:  Christian K Brinkmann; Petrus Chang; Tina Schick; Britta Heimes; Jessica Vögeler; Birgit Haegele; Bernd Kirchhof; Frank G Holz; Daniel Pauleikhoff; Focke Ziemssen; Sandra Liakopoulos; Georg Spital; Steffen Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2019-08       Impact factor: 1.059

4.  Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa.

Authors:  Amelie Pielen; Anima Desiree Bühler; Sonja Ute Heinzelmann; Daniel Böhringer; Thomas Ness; Bernd Junker
Journal:  J Ophthalmol       Date:  2017-07-30       Impact factor: 1.909

5.  A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.

Authors:  Katrin Lorenz; Yvonne Scheller; Katharina Bell; Franz Grus; Katharina A Ponto; Felix Bock; Claus Cursiefen; Jens Flach; Marta Gehring; Tunde Peto; Rufino Silva; Yossi Tal; Norbert Pfeiffer
Journal:  Trials       Date:  2017-03-16       Impact factor: 2.279

Review 6.  Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.

Authors:  Heinrich Gerding; Jordi Monés; Ramin Tadayoni; Francesco Boscia; Ian Pearce; Siegfried Priglinger
Journal:  Br J Ophthalmol       Date:  2014-07-29       Impact factor: 4.638
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.